The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.
We are thrilled to announce the return of NephCure’s 17th Annual All In for a Cure: Charity Golf and Texas Hold ‘Em event on Thursday, May 23rd at Glen Head Country Club! Prepare for a beautiful day of golf followed by an exciting Texas Hold ‘Em style tournament in the evening. As always, all proceeds are in support of NephCure’s vital mission of saving kidneys and saving lives. Register Today!
240 Glen Cove Road, Glen Head, NY 11545
Thank you to our generous sponsors for supporting NephCure Community Days!
NephCure is a registered non-profit (501c3) tax-exempt charitable organization. EIN # 38-3569922.
© Copyright 2024 NephCure, Inc. All rights reserved worldwide. NephCure, and the logo, are federally registered trademarks of NephCure, Inc.
EN 
ES 